Anchor Investment Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.37M | Sell |
8,086
-1,069
| -12% | -$351K | 0.2% | 125 |
|
|
2025
Q4 | $3.21M | Buy |
9,155
+1,267
| +16% | +$428K | 0.26% | 102 |
|
|
2025
Q3 | $2.55M | Buy |
7,888
+1,010
| +15% | +$314K | 0.21% | 120 |
|
|
2025
Q2 | $2.68M | Buy |
6,878
+388
| +6% | +$156K | 0.23% | 113 |
|
|
2025
Q1 | $2.82M | Sell |
6,490
-911
| -12% | -$366K | 0.26% | 98 |
|
|
2024
Q4 | $2.73M | Buy |
7,401
+1,303
| +21% | +$545K | 0.25% | 104 |
|
|
2024
Q3 | $3.17M | Buy |
6,098
+1,135
| +23% | +$606K | 0.3% | 89 |
|
|
2024
Q2 | $2.69M | Buy |
4,963
+204
| +4% | +$108K | 0.28% | 94 |
|
|
2024
Q1 | $2.47M | Buy |
4,759
+208
| +5% | +$103K | 0.26% | 104 |
|
|
2023
Q4 | $2.15M | Buy |
4,551
+1,142
| +33% | +$528K | 0.25% | 107 |
|
|
2023
Q3 | $1.48M | Sell |
3,409
-540
| -14% | -$245K | 0.19% | 123 |
|
|
2023
Q2 | $1.75M | Buy |
3,949
+166
| +4% | +$76.6K | 0.22% | 117 |
|
|
2023
Q1 | $1.74M | Buy |
3,783
+280
| +8% | +$133K | 0.24% | 113 |
|
|
2022
Q4 | $1.8M | Buy |
3,503
+68
| +2% | +$34.5K | 0.26% | 112 |
|
|
2022
Q3 | $1.56M | Buy |
3,435
+172
| +5% | +$82.3K | 0.24% | 110 |
|
|
2022
Q2 | $1.57M | Buy |
3,263
+61
| +2% | +$30.2K | 0.23% | 114 |
|
|
2022
Q1 | $1.57M | Buy |
3,202
+224
| +8% | +$102K | 0.2% | 122 |
|
|
2021
Q4 | $1.38M | Buy |
2,978
+156
| +6% | +$65.6K | 0.17% | 130 |
|
|
2021
Q3 | $1.05M | Buy |
2,822
+51
| +2% | +$19.4K | 0.15% | 155 |
|
|
2021
Q2 | $1.06M | Sell |
2,771
-2
| -0.1% | -$764 | 0.15% | 152 |
|
|
2021
Q1 | $995K | Buy |
2,773
+1,195
| +76% | +$384K | 0.15% | 146 |
|
|
2020
Q4 | $507K | Buy |
1,578
+113
| +8% | +$34.7K | 0.09% | 187 |
|
|
2020
Q3 | $393K | Buy |
1,465
+72
| +5% | +$19.4K | 0.08% | 187 |
|
|
2020
Q2 | $366K | Sell |
1,393
-81
| -5% | -$21.6K | 0.08% | 186 |
|
|
2020
Q1 | $335K | Buy |
1,474
+439
| +42% | +$120K | 0.09% | 187 |
|
|
2019
Q4 | $313K | Sell |
1,035
-29
| -3% | -$7.98K | 0.07% | 221 |
|
|
2019
Q3 | $255K | Buy |
1,064
+63
| +6% | +$17.3K | 0.06% | 250 |
|
|
2019
Q2 | $282K | Buy |
1,001
+176
| +21% | +$48.1K | 0.07% | 232 |
|
|
2019
Q1 | $237K | Buy |
825
+465
| +129% | +$134K | 0.06% | 258 |
|
|
2018
Q4 | $94.5K | Hold |
360
| – | – | 0.03% | 351 |
|
|
2018
Q3 | $98.7K | Hold |
360
| – | – | 0.02% | 379 |
|
|
2018
Q2 | $85.7K | Hold |
360
| – | – | 0.02% | 407 |
|
|
2018
Q1 | $79.1K | Hold |
360
| – | – | 0.02% | 421 |
|
|
2017
Q4 | $81K | Hold |
360
| – | – | 0.02% | 403 |
|
|
2017
Q3 | $68.4K | Hold |
360
| – | – | 0.02% | 414 |
|
|
2017
Q2 | $67.7K | Hold |
360
| – | – | 0.02% | 373 |
|
|
2017
Q1 | $59.5K | Hold |
360
| – | – | 0.02% | 377 |
|
|
2016
Q4 | $51.8K | Hold |
360
| – | – | 0.02% | 379 |
|
|
2016
Q3 | $45.1K | Buy |
360
+60
| +20% | +$7.75K | 0.02% | 363 |
|
|
2016
Q2 | $39.4K | Hold |
300
| – | – | 0.02% | 376 |
|
|
2016
Q1 | $41.7K | Buy |
+300
| New | +$40.1K | 0.02% | 360 |
|
Other funds holding ELV
VCM
VPM
Anchor Investment Management's ELV Position: Q1 2026 in Review
Anchor Investment Management reduced its Elevance Health (ELV) stake by 12% in Q1 2026, selling an estimated $351K and leaving 8,086 shares worth $2.37M. The position accounts for 0.2% of the portfolio, ranked #125.
Anchor Investment Management first reported a position in ELV in Q1 2016 and has held it in 41 quarters since. The position peaked at $3.21M in Q4 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Anchor Investment Management held 8,086 shares of Elevance Health worth $2.37M as of Q1 2026.
- Anchor Investment Management sold 1,069 Elevance Health shares in Q1 2026, an estimated $351K.
- Elevance Health made up 0.2% of Anchor Investment Management's portfolio in Q1 2026, its #125 holding.
- Anchor Investment Management first reported a position in Elevance Health in Q1 2016 and has held it in 41 quarters since.
- Anchor Investment Management's Elevance Health position peaked at $3.21M in Q4 2025.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Anchor Investment Management's 13F filing for Q1 2026, filed 1 May 2026.